News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
831,923 Results
Type
Article (85638)
Company Profile (703)
Press Release (745582)
Section
Business (231984)
Career Advice (4115)
Deals (39674)
Drug Delivery (120)
Drug Development (90644)
Employer Resources (194)
FDA (17932)
Job Trends (17281)
News (395105)
Policy (39600)
Tag
Academia (2972)
Alliances (56524)
Alzheimer's disease (1375)
Antibody-drug conjugate (ADC) (104)
Approvals (17895)
Artificial intelligence (153)
Bankruptcy (396)
Best Places to Work (12485)
Biotechnology (485)
Breast cancer (169)
Cancer (1385)
Career advice (3518)
CAR-T (116)
Cell therapy (336)
Clinical research (71879)
Collaboration (547)
Compensation (258)
COVID-19 (2799)
C-suite (123)
Data (1257)
Diabetes (138)
Diagnostics (6633)
Earnings (94208)
Employer resources (166)
Events (126859)
Executive appointments (417)
FDA (18540)
Funding (450)
Gene therapy (230)
GLP-1 (671)
Government (5034)
Healthcare (20686)
Infectious disease (2880)
Inflammatory bowel disease (128)
Interviews (808)
IPO (17604)
Job creations (5180)
Job search strategy (2856)
Layoffs (495)
Legal (10026)
Lung cancer (209)
Manufacturing (211)
Medical device (14262)
Medtech (14267)
Mergers & acquisitions (22121)
Metabolic disorders (448)
Neuroscience (1720)
NextGen: Class of 2025 (7657)
Non-profit (5054)
Northern California (1654)
Obesity (249)
Opinion (252)
Patents (115)
People (64334)
Pharmaceutical (142)
Phase I (22183)
Phase II (31238)
Phase III (23508)
Pipeline (552)
Postmarket research (3541)
Preclinical (9980)
Radiopharmaceuticals (245)
Rare diseases (270)
Real estate (7371)
Regulatory (26029)
Research institute (2640)
Resumes & cover letters (649)
Southern California (1435)
Startups (4276)
United States (14870)
Vaccines (641)
Weight loss (197)
Date
Today (92)
Last 7 days (325)
Last 30 days (1606)
Last 365 days (33157)
2025 (1510)
2024 (34082)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57670)
2019 (51341)
2018 (39125)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1261)
Arizona (219)
Asia (49450)
Australia (8725)
California (3795)
Canada (1264)
China (341)
Colorado (121)
Connecticut (163)
Europe (113099)
Florida (445)
Illinois (377)
Indiana (215)
Kansas (105)
Maryland (673)
Massachusetts (3099)
Michigan (159)
Minnesota (270)
New Jersey (1071)
New York (1053)
North Carolina (852)
Northern California (1654)
Ohio (129)
Pennsylvania (838)
South America (1646)
Southern California (1435)
Texas (497)
Washington State (411)
831,923 Results for "sensei bio".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sensei Biotherapeutics Provides Corporate Update and Highlights Key Upcoming Milestones
January 8, 2025
·
5 min read
Press Releases
Sensei Biotherapeutics to Participate in Citi’s 2024 Global Healthcare Conference
November 28, 2024
·
1 min read
Genetown
Sensei Biotherapeutics to Participate in Jefferies Global Healthcare Conference
Sensei Biotherapeutics, Inc. today announced that John Celebi, President and Chief Executive Officer, will present at the Jefferies Global Healthcare Conference, being held in New York, NY, on Thursday, June 6, 2024 at 8:30 a.m. ET.
May 30, 2024
·
1 min read
Press Releases
Sensei Biotherapeutics to Present at Two Upcoming Scientific Conferences
October 29, 2024
·
2 min read
Press Releases
Sensei Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
November 15, 2024
·
8 min read
Business
Sensei Biotherapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
Sensei Biotherapeutics, Inc. reported financial results for the first quarter ended March 31, 2024, and provided corporate updates.
May 9, 2024
·
9 min read
Genetown
Sensei Biotherapeutics to Participate in the 3rd Annual VISTA Symposium
Sensei Biotherapeutics, Inc. today announced that Company management will participate on a panel titled ‘Anti-VISTA Immunotherapies in Clinical Development’ at the 3rd Annual VISTA Symposium.
March 22, 2024
·
2 min read
Press Releases
Sensei Biotherapeutics to Present at Upcoming Conferences in September 2024
September 5, 2024
·
1 min read
Genetown
Sensei Biotherapeutics to Present New Preclinical Data at Upcoming Scientific Conferences
Sensei Biotherapeutics, Inc. today announced that the company will present preclinical data on its conditionally active immuno-oncology programs at upcoming scientific conferences.
March 6, 2024
·
4 min read
Drug Development
Sensei Biotherapeutics Presents Promising Clinical Data from Phase 1 Dose Escalation Study of SNS-101
Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients, today reported encouraging clinical data from the dose escalation portion of its Phase 1/2 trial of SNS-101, a conditionally active, human monoclonal antibody targeting the immune checkpoint VISTA (V-domain Ig suppressor of T cell activation).
May 23, 2024
·
9 min read
1 of 83,193
Next
